Jump to Navigation
Home
News
Daily News
Documents
Health Insider
Abortion Roundup
Special Opioid Report
Topics
Transition 2025
Post-Chevron
Biden Health Agenda
Artificial Intelligence
Coronavirus
Abortion
Health Equity
Health Reform Debate
Opioids
Medicaid
Medicare
Rx Drugs
Medical Devices
Congress
ACOs
Emergency Response
The Courts
21st Century Cures
Budget
Cybersecurity
Food Safety
Tobacco
User Fees
Waste and Fraud
FDA Week
Inside CMS
Inside Drug Pricing
Latest News
Documents
Health Exchange Alert
Latest News
Documents
Inside TeleHealth
About Us
About Us
Privacy Policy
Terms and Conditions
Login Help
Thursday, April 24, 2025
FDA Press Release
Guidance For Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment
Guidance For Premarketing Risk Assessment
Guidance For Risk Minimization Action Plans
/index.php?option=com_iwpfile&file=/dir_05/he2005_0757.pdf
/index.php?option=com_iwpfile&file=/dir_05/he2005_0756.pdf
/index.php?option=com_iwpfile&file=/dir_05/he2005_0755.pdf
t
Public Citizen Press Release
Public Citizen Petition
/index.php?option=com_iwpfile&file=/dir_05/he2005_0753.pdf
/index.php?option=com_iwpfile&file=/dir_05/he2005_0752.pdf
/index.php?option=com_iwpfile&file=/dir_05/he2005_0751.pdf
/index.php?option=com_iwpfile&file=/dir_05/he2005_0750.pdf
/index.php?option=com_iwpfile&file=/dir_05/he2005_0749.pdf
Pages
« first
‹ previous
…
5958
5959
5960
5961
5962
5963
5964
5965
5966
…
next ›
last »
Log in to access this content.
Username
*
Password
*
Remember me
Not a subscriber?
Sign up for 30 days free access
to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.